Judy Stein

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Martin R. Gaudinski, Katherine V. Houser, Kaitlyn M. Morabito et al. · The Lancet · 2017 · 304 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

Katherine V. Houser, Grace Chen, Cristina Carter et al. · Nature Medicine · 2022 · 163 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial

Uzma Sarwar, Pamela Costner, Mary E. Enama et al. · The Journal of Infectious Diseases · 2014 · 133 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

Martin R. Gaudinski, Emily E. Coates, Laura Novik et al. · The Lancet · 2019 · 128 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +14

Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria

Richard L Wu, Azza H. Idris, Nina M. Berkowitz et al. · New England Journal of Medicine · 2022 · 124 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17